Clinical Trial Update: A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors

View source ↗

Summary

A pilot clinical trial update evaluating blood-based biomarkers to predict response to immune checkpoint inhibitors in non-small cell lung cancer and renal cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Renal Cell Carcinoma

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Non-Small Cell Lung Cancer, Renal Cell Carcinoma (RCC) | Status: ACTIVE_NOT_RECRUITING